Page last updated: 2024-08-21

fluorobenzenes and Infarct

fluorobenzenes has been researched along with Infarct in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Die, J; Fan, L; Jiang, Y; Shi, Z; Wang, K	1

Other Studies

1 other study(ies) available for fluorobenzenes and Infarct

Article	Year
Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions. Brain research, 2010, Jul-30, Volume: 1346 Topics: Animals; Biomarkers; Blotting, Western; Fluorobenzenes; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Infarction; Ischemic Preconditioning; Locomotion; Male; Mevalonic Acid; Neuroprotective Agents; Nitric Oxide Synthase; Pyrimidines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosuvastatin Calcium; Spinal Cord Ischemia; Sulfonamides; Treatment Outcome	2010

Article

Year

Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.

Brain research, 2010, Jul-30, Volume: 1346

Topics: Animals; Biomarkers; Blotting, Western; Fluorobenzenes; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Infarction; Ischemic Preconditioning; Locomotion; Male; Mevalonic Acid; Neuroprotective Agents; Nitric Oxide Synthase; Pyrimidines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosuvastatin Calcium; Spinal Cord Ischemia; Sulfonamides; Treatment Outcome

2010